Jiangtangjing ameliorates type 2 diabetes through effects on the gut microbiota and cAMP/PKA pathway

Previous studies have reported the therapeutic effects of oleuropein (OP) consumption on the early stage of type 2 diabetes. However, the efficacy of OP on the advanced stage of type 2 diabetes has not been investigated, and the relationship between OP and intestinal flora has not been studied. Therefore, in this study, to explore the relieving effects of OP intake on the advanced stage of type 2 diabetes and the regulatory effects of OP on intestinal microbes, diabetic db/db mice (17-week-old) were treated with OP at the dose of 200 mg/kg for 15 weeks. We found that OP has a significant effect in decreasing fasting blood glucose levels, improving glucose tolerance, lowering the homeostasis model assessment–insulin resistance index, restoring histopathological features of tissues, and promoting hepatic protein kinase B activation in db/db mice. Notably, OP modulates gut microbiota at phylum level, increases the relative abundance of Verrucomicrobia and Deferribacteres, and decreases the relative abundance of Bacteroidetes. OP treatment increases the relative abundance of Akkermansia, as well as decreases the relative abundance of Prevotella, Odoribacter, Ruminococcus, and Parabacteroides at genus level. In conclusion, OP may ameliorate the advanced stage of type 2 diabetes through modulating the composition and function of gut microbiota. Our findings provide a promising therapeutic approach for the treatment of advanced stage type 2 diabetes.

Download Full-text

The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre

Acta Diabetologica ◽

10.1007/s00592-021-01727-5 ◽

2021 ◽

Author(s):

Dominic Salamone ◽

Angela Albarosa Rivellese ◽

Claudia Vetrani

Keyword(s):

Type 2 Diabetes ◽

Fatty Acids ◽

Gut Microbiota ◽

Dietary Fibre ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Microbiota Composition ◽

The Relationship ◽

Chain Fatty Acids

AbstractGut microbiota and its metabolites have been shown to influence multiple physiological mechanisms related to human health. Among microbial metabolites, short-chain fatty acids (SCFA) are modulators of different metabolic pathways. On the other hand, several studies suggested that diet might influence gut microbiota composition and activity thus modulating the risk of metabolic disease, i.e. obesity, insulin resistance and type 2 diabetes. Among dietary component, dietary fibre may play a pivotal role by virtue of its prebiotic effect on fibre-fermenting bacteria, that may increase SCFA production. The aim of this review was to summarize and discuss current knowledge on the impact of dietary fibre as modulator of the relationship between glucose metabolism and microbiota composition in humans. More specifically, we analysed evidence from observational studies and randomized nutritional intervention investigating the relationship between gut microbiota, short-chain fatty acids and glucose metabolism. The possible mechanisms behind this association were also discussed.

Download Full-text

Gut microbiota influence in type 2 diabetes mellitus (T2DM)

Gut Pathogens ◽

10.1186/s13099-021-00446-0 ◽

2021 ◽

Vol 13 (1) ◽

Author(s):

A. L. Cunningham ◽

J. W. Stephens ◽

D. A. Harris

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Gut Microbiota ◽

Potential Role ◽

Evidence Base ◽

Human Metabolism ◽

Altered Glucose

AbstractA strong and expanding evidence base supports the influence of gut microbiota in human metabolism. Altered glucose homeostasis is associated with altered gut microbiota, and is clearly associated with the development of type 2 diabetes mellitus (T2DM) and associated complications. Understanding the causal association between gut microbiota and metabolic risk has the potential role of identifying susceptible individuals to allow early targeted intervention.

Download Full-text

An alcohol-free beer enriched with isomaltulose and a resistant dextrin modulates gut microbiome in subjects with type 2 diabetes mellitus and overweight or obesity: a pilot study

Food & Function ◽

10.1039/d0fo03160g ◽

2021 ◽

Author(s):

Rocío Mateo-Gallego ◽

Isabel Moreno-Indias ◽

Ana M. Bea ◽

Lidia Sánchez-Alcoholado ◽

Antonio J. Fumanal ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Pilot Study ◽

Gut Microbiota ◽

Gut Microbiome ◽

Low Doses ◽

Resistant Dextrin ◽

Overweight Or Obesity

An alcohol-free beer including the substitution of regular carbohydrates for low doses of isomaltulose and maltodextrin within meals significantly impacts gut microbiota in diabetic subjects with overweight or obesity.

Download Full-text

Fermented carrot juice attenuates type 2 diabetes by mediating gut microbiota in rats

Food & Function ◽

10.1039/c9fo00475k ◽

2019 ◽

Vol 10 (5) ◽

pp. 2935-2946 ◽

Cited By ~ 10

Author(s):

Rongkang Hu ◽

Feng Zeng ◽

Linxiu Wu ◽

Xuzhi Wan ◽

Yongfang Chen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Fatty Acid ◽

Gut Microbiota ◽

Short Chain Fatty Acid ◽

Lactobacillus Rhamnosus ◽

Chain Fatty Acid ◽

Carrot Juice ◽

Protein Expressions ◽

Free Phenolics

Carrot juice fermented with Lactobacillus rhamnosus GG, enriched with free phenolics, organic acids and short-chain fatty acid, has the potential to ameliorate type 2 diabetes, in part through modulating specific gut microbiota and regulating the mRNA and protein expressions levels involved in glucose metabolism.

Download Full-text

Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity

Journal of Diabetes & Metabolic Disorders ◽

10.1007/s40200-021-00858-4 ◽

2021 ◽

Author(s):

A. L. Cunningham ◽

J. W. Stephens ◽

D. A. Harris

Keyword(s):

Type 2 Diabetes ◽

Gut Microbiota ◽

Current Knowledge ◽

Intestinal Barrier ◽

Short Chain Fatty Acids ◽

Global Epidemic ◽

Technological Advances ◽

Diabetes And Obesity

AbstractObesity and type 2 diabetes mellitus (T2DM) are common, chronic metabolic disorders with associated significant long-term health problems at global epidemic levels. It is recognised that gut microbiota play a central role in maintaining host homeostasis and through technological advances in both animal and human models it is becoming clear that gut microbiota are heavily involved in key pathophysiological roles in the aetiology and progression of both conditions. This review will focus on current knowledge regarding microbiota interactions with short chain fatty acids, the host inflammatory response, signaling pathways, integrity of the intestinal barrier, the interaction of the gut-brain axis and the subsequent impact on the metabolic health of the host.

Download Full-text

Differential gut microbiota composition between type 2 diabetes mellitus patients and healthy controls: A systematic review

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108689 ◽

2021 ◽

Vol 173 ◽

pp. 108689 ◽

Cited By ~ 1

Author(s):

Fatin Umirah ◽

Chin Fen Neoh ◽

Kalavathy Ramasamy ◽

Siong Meng Lim

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Gut Microbiota ◽

Healthy Controls ◽

Microbiota Composition ◽

Gut Microbiota Composition

Download Full-text

Arabinoxylan ameliorates type 2 diabetes by regulating the gut microbiota and metabolites

Food Chemistry ◽

10.1016/j.foodchem.2021.131106 ◽

2022 ◽

Vol 371 ◽

pp. 131106

Author(s):

Qixing Nie ◽

Jielun Hu ◽

Haihong Chen ◽

Fang Geng ◽

Shaoping Nie

Keyword(s):

Type 2 Diabetes ◽

Gut Microbiota

Download Full-text

Rotundic Acid Protects against Metabolic Disturbance and Improves Gut Microbiota in Type 2 Diabetes Rats

Nutrients ◽

10.3390/nu12010067 ◽

2019 ◽

Vol 12 (1) ◽

pp. 67 ◽

Cited By ~ 1

Author(s):

Zenghao Yan ◽

Hao Wu ◽

Hongliang Yao ◽

Wenjun Pan ◽

Minmin Su ◽

...

Keyword(s):

Type 2 Diabetes ◽

Gut Microbiota ◽

Southern China ◽

16S Rrna Gene Sequencing ◽

Metabolic Disturbance ◽

Lipid Lowering ◽

Rrna Gene ◽

Illumina Hiseq ◽

Rotundic Acid

Rotundic acid (RA) is a major triterpene constituent in the barks of Ilex rotunda Thunb, which have been widely used to make herbal tea for health care in southern China. RA has a variety of bioactivities such as anti-inflammation and lipid-lowering effect. However, little is known about the effects and mechanisms of RA on metabolic disturbance in type 2 diabetes (T2D) and its effect on gut microbiota. A T2D rat model induced by high fat diet (HFD) feeding and low-dose streptozotocin (STZ) injection was employed and RA showed multipronged effects on T2D and its complications, including improving glucolipid metabolism, lowering blood pressure, protecting against cardiovascular and hepatorenal injuries, and alleviating oxidative stress and inflammation. Furthermore, 16s rRNA gene sequencing was carried out on an Illumina HiSeq 2500 platform and RA treatment could restore the gut microbial dysbiosis in T2D rats to a certain extent. RA treatment significantly enhanced the richness and diversity of gut microbiota. At the genus level, beneficial or commensal bacteria Prevotella, Ruminococcus, Leuconostoc and Streptococcus were significantly increased by RA treatment, while RA-treated rats had a lower abundance of opportunistic pathogen Klebsiella and Proteus. Spearman’s correlation analysis showed that the abundances of these bacteria were strongly correlated with various biochemical parameters, suggesting that the improvement of gut microbiota might help to prevent or attenuate T2D and its complication. In conclusion, our findings support RA as a nutraceutical agent or plant foods rich in this compound might be helpful for the alleviation of T2D and its complications through improving gut microbiota.

Download Full-text